How group A strep and mouth bacteria control strep throat damage
Molecular Mechanism of Virulence Regulation in Streptococcus Pyogenes
Researchers are learning how the strep throat germ and friendly mouth bacteria communicate in the throat so new ways to prevent or treat strep infections can be developed.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11094745 on NIH RePORTER |
What this research studies
This project looks at the chemical signals and proteins that group A Streptococcus (the germ that causes strep throat) uses to turn on its harmful factors and how nearby harmless mouth bacteria make small antimicrobials that fight it. Scientists will identify the antimicrobial molecule made by the commensal bacteria, study how the strep enzyme SpeB breaks it down, and map bacterial signaling systems that time virulence. Work combines bacterial cultures, biochemical analysis, genetic tools, and infection models that mimic the human throat. The team aims to find targets that could lead to new drugs or ways to strengthen protective microbes in the mouth.
Who could benefit from this research
Good fit: People who get recurrent strep throat or volunteers willing to provide throat swabs or other oral samples would be the most relevant candidates to support this research.
Not a fit: People without throat infections or whose symptoms are caused by non–group A strep bacteria may not see direct benefit from this specific work.
Why it matters
Potential benefit: If successful, this work could lead to new treatments or prevention methods that stop strep throat by blocking harmful signals or boosting protective mouth bacteria.
How similar studies have performed: Previous research has shown bacterial signaling and commensal microbes can affect pathogen behavior, but applying these specific findings to prevent or treat strep throat is a newer and developing approach.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Kumaraswami, Muthiah — Methodist Hospital Research Institute
- Study coordinator: Kumaraswami, Muthiah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.